Search this site
Welcome
  • maheshsundar.com
    • The Speaking Tree
    • Pharma Glimpses
  • Contact Me
Welcome
  • maheshsundar.com
    • The Speaking Tree
    • Pharma Glimpses
  • Contact Me
  • More
    • maheshsundar.com
      • The Speaking Tree
      • Pharma Glimpses
    • Contact Me

Pharma glimpses

The Front Pages

Viatris to shut or sell two plants in India as part of global restructuring exercise


  • Top 15 Best-Selling Drugs Launched in 2020

  • Company Focus: Aurobindo Pharma Ltd. (Mint Publication)

  • Viatris' growth story hinges on M&A as China, Japan hang in the balance: analyst

  • List of 53 APIs nominated under the Indian Govt. incentive scheme - source, Business Today

  • FDA kicks off GDUFA III reauthorization process

  • Piramal sells 20% stake to Carlyle for $490Bn - Business Standard

  • Sanofi's API spin off worth €2B - Fierce Pharma


Industry stats & reports

  • IQVIA Report - Global Use of Medicines 2020 (Global Stats and Updates)

  • Pharmexec - 2020 Top 50 Pharmaceutical Companies

  • IQVIA Report - Impact of Covid-19 on Global Healthcare

  • Pharma API Report: API Sourcing: The Supply Side for US-Marketed Drugs (DCAT Report)

FDA Resources:

  • Generic Approvals by Month

  • First Time Generic Approvals

  • Novel Drug Approvals

  • Drug Shortages


  • List of DMFs Filed

  • GDUFA Paid Facilities List

  • FDA Warning Letters Listings

Articles and Reports


Global Market Reports:

  • 2019 - Highlights of China's Healthcare Industry - CPhI

  • IQVIA: Winning in the Indian Pharmaceutical Market

  • Ayushman India - A Perspective

  • PharmaBoardroom: India Country Report 2018

  • Pharmaboardroom: Europe Pharma Data by Country 2020


Generics:

  • IQVIA: US Generics Market Evolution of Indian Players

  • IQVIA: Complex Generics - Charting a New Path

Report abuse
Report abuse